This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Simvastatin cost advantage in 2° CHD prevention. Pharmacoecon. Outcomes News 311, 6 (2001). https://doi.org/10.1007/BF03280320
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280320